Product image of Meropenem Qilu (Meropenem) supplied by GNH India

Meropenem Qilu

Active Ingredient:
Meropenem
Origin:
EU

Meropenem Qilu (Meropenem)

Meropenem, the active ingredient in Meropenem Qilu, is a carbapenem antibiotic presented as a sterile powder for reconstitution for intravenous use. It treats severe bacterial infections such as intra‑abdominal infections, hospital‑acquired pneumonia, meningitis, and sepsis in adult and pediatric patients when other therapies are unsuitable.

GNH India supplies Meropenem Qilu as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Qilu Pharma Spain S.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Meropenem is a broad‑spectrum carbapenem used for serious bacterial infections across several organ systems.

  • Complicated intra‑abdominal infections: provides bactericidal activity against mixed aerobic and anaerobic pathogens.
  • Complicated urinary tract infections: eradicates resistant Gram‑negative organisms causing severe UTIs.
  • Hospital‑acquired pneumonia: treats ventilator‑associated and other nosocomial pneumonias.
  • Meningitis: penetrates the cerebrospinal fluid to eliminate causative bacteria.
  • Severe sepsis: offers rapid bacterial clearance in systemic infections.

How It Works

  • Meropenem binds with high affinity to penicillin‑binding proteins (PBPs) on bacterial cell walls, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic instability and bacterial cell death. Its broad spectrum includes many Gram‑negative, Gram‑positive, and anaerobic organisms, and it resists most β‑lactamases, providing potent bactericidal activity.

Side Effects

Adverse reactions may vary in frequency and severity.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: may be watery and self‑limiting.
  • Rash: erythematous skin eruptions.
  • Infusion site reactions: pain, erythema, or phlebitis.
  • Elevated liver enzymes: transient transaminase increase.
  • Headache: mild to moderate intensity.

Serious or Rare Side Effects

  • Seizures: especially in patients with renal impairment or CNS disease.
  • Anaphylaxis: acute hypersensitivity requiring immediate intervention.
  • Clostridioides difficile colitis: severe diarrhea due to gut flora disruption.
  • Severe neutropenia: marked reduction in neutrophil count.
  • Renal toxicity: worsening kidney function in susceptible individuals.
  • Hypersensitivity reactions: including Stevens‑Johnson syndrome.

Precautions & Warnings

Careful assessment and monitoring are essential when using Meropenem.

  • Renal function: adjust dose in patients with impaired clearance.
  • Allergy history: avoid if known hypersensitivity to carbapenems or β‑lactams.
  • Pregnancy: use only when benefits outweigh potential risks.
  • Concomitant valproic acid: monitor for decreased serum levels.
  • Superinfection: watch for fungal or opportunistic bacterial overgrowth.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Meropenem may interact with several drugs, requiring vigilance.

Major Interactions (Avoid)

  • Valproic acid: reduces antiepileptic serum concentrations.
  • Phenobarbital: may increase meropenem clearance, lowering efficacy.
  • Renally toxic agents (e.g., aminoglycosides): heightened risk of kidney injury.

Moderate Interactions (Monitor Closely)

  • Loop diuretics: monitor renal function and electrolytes.
  • Aminoglycosides: assess for additive nephrotoxicity.
  • Anticoagulants (warfarin): observe INR for potential alterations.

Frequently Asked Questions

Meropenem Qilu is indicated for serious bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, hospital‑acquired pneumonia, meningitis, and severe sepsis. It is employed when the causative organisms are resistant to other antibiotics or when a broad‑spectrum agent is required.

Meropenem inhibits bacterial cell wall synthesis by binding to penicillin‑binding proteins, preventing the cross‑linking of peptidoglycan strands. This leads to loss of cell wall integrity and bacterial cell death, providing a bactericidal effect against a wide range of Gram‑positive, Gram‑negative, and anaerobic organisms.

The dosing regimen for Meropenem Qilu is determined by the prescribing clinician based on the type and severity of infection, patient age, weight, and renal function. Healthcare professionals tailor the dose and infusion schedule to achieve optimal therapeutic outcomes.

Safety data for Meropenem in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant. Clinicians should discuss the risk‑benefit profile with the patient before initiating therapy.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Meropenem shares a similar spectrum with other carbapenems such as imipenem and ertapenem but offers a broader activity against Pseudomonas aeruginosa and better stability against many β‑lactamases. Its dosing flexibility and lower risk of seizures compared with imipenem make it a preferred choice in many severe infections.

Meropenem Qilu should be stored at 2‑8 °C in a refrigerator, protected from light, and kept in its original packaging to maintain stability. Do not freeze or shake the reconstituted solution; use within the time frame specified in the product labeling.

Meropenem Qilu is supplied as a sterile powder for reconstitution and is administered intravenously. The reconstituted solution is infused over a prescribed period, typically 15‑30 minutes, under aseptic conditions by qualified healthcare personnel.

The most serious adverse events include seizures, especially in patients with renal impairment or pre‑existing CNS disorders, severe hypersensitivity reactions such as anaphylaxis, and Clostridioides difficile‑associated colitis. Prompt recognition and management of these events are essential.

Meropenem Qilu is contraindicated in patients with a known hypersensitivity to carbapenems, other β‑lactam antibiotics, or any component of the formulation. Caution is also advised for patients with a history of seizures, severe renal impairment, or those receiving interacting medications without appropriate monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Meropenem

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT